The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Listen to the Lungs: An Interview with Dr. Aryeh Fischer on ILD

Listen to the Lungs: An Interview with Dr. Aryeh Fischer on ILD

January 29, 2016 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

lungs_BSIP-SA_Alamy_500x270If Aryeh Fischer, MD, could tell rheumatologists one thing about interstitial lung disease (ILD), it would be to listen to their patients’ lungs.

You Might Also Like
  • What Our Colleagues Should Know: Integrated Care for the Lungs
  • Summit on Connective Tissue Disease-Associated ILD Fosters Interdisciplinary Dialogue
  • Treatment Tips for Pulmonary Arterial Hypertension & ILD
Also By This Author
  • One-Third of Total Knee Replacements May Be Inappropriate

“What we hear from the pulmonologists is, ‘Why don’t we see these patients earlier?’” says Dr. Fischer, associate professor of medicine, Division of Rheumatology, Division of Pulmonary Sciences and Critical Care Medicine, at University of Colorado School of Medicine in Denver. “A real call to action as rheumatologists is to be more aware of interstitial lung disease and to try to diagnose it earlier. Let’s ask about shortness of breath, listen to our patients’ lungs [and] order chest imaging. And let’s try to get these patients diagnosed earlier because early detection should lead to better outcomes.

Aryeh Fischer, MD

Aryeh Fischer, MD

Recently, Dr. Fischer talked with The Rheumatologist about ILD:

Q: How common is ILD?
A: It’s quite common in systemic autoimmune patients, but it really depends on which type of disease we’re discussing. For systemic sclerosis, upward of 80 or 90% of patients may have a component of interstitial lung disease. It may only come to clinical relevance in somewhere around 30% [of cases]. But it’s the leading cause of death in systemic sclerosis. It’s quite prevalent in muscle inflammatory diseases …, and there’s a growing appreciation that it’s common in rheumatoid arthritis, as well.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Q: Why do you say a ‘growing appreciation’?
A: People are looking for it more. Technology has advanced, and we have better imaging modalities than ever before. So the high-resolution CT scan really has allowed us to get a better appreciation for types of lung disease, patterns and, perhaps, more in the way of prevalence. … It’s a combination of both seeking it out and having the technology to go look for it.

Q: Should all rheumatologists keep ILD in front of mind?
A: The reality for rheumatology is [that] there’s a lot we’ve got to keep track of. There’s already an appreciation that heart disease is a real threat and our [patient] population is at a higher risk. Similarly, we know that our patients—particularly those with systemic autoimmune conditions are at risk for lung involvement. … We should be listening to their lungs and asking them about lung disease. … It’s a game changer, because [ILD] can be life threatening.

Richard Quinn is a freelance writer in New Jersey.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Conditions Tagged With: ILD, Interstitial Lung Disease, lung, lung disease, Systemic sclerosis

You Might Also Like:
  • What Our Colleagues Should Know: Integrated Care for the Lungs
  • Summit on Connective Tissue Disease-Associated ILD Fosters Interdisciplinary Dialogue
  • Treatment Tips for Pulmonary Arterial Hypertension & ILD
  • From the Expert: New Advances in Treatment of Systemic Scleroderma

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)